Somatostatin receptor scintigraphy and somatostatin therapy in the evaluation and treatment of malignant thymoma

被引：37

作者：

Lin, K

Nguyen, BD

Ettinger, DS

Chin, BB

机构：

[1] Johns Hopkins Med Inst, Dept Radiol & Radiol Sci, Baltimore, MD 21287 USA

[2] Johns Hopkins Med Inst, Dept Med Oncol, Baltimore, MD 21287 USA

来源：

CLINICAL NUCLEAR MEDICINE | 1999年 / 24卷 / 01期

关键词：

thymoma; In-111-octreotide scintigraphy; somatostatin therapy;

D O I：

10.1097/00003072-199901000-00006

中图分类号：

R8 [特种医学]; R445 [影像诊断学];

学科分类号：

1002 ; 100207 ; 1009 ;

摘要：

Purpose: This report illustrates the potential diagnostic and therapeutic utility of somatostatin receptor scintigraphy and therapy with somatostatin. Methods: In-ill pentetreotide (In-ll octreotide), a somatostatin analog, was used to define the receptor status and the extent of disease in a case of malignant thymoma, Results: Subsequent treatment with nonradioactive somatostatin inhibited tumor growth, Conclusion: In-ill octreotide may be usfeul to define tumor receptor status and may provide prognostic information useful in determining subsequent therapy.

引用

页码：24 / 28

页数：5

共 30 条

[1] CLINICAL EFFICACY OF OCTREOTIDE SCINTIGRAPHY IN PATIENTS WITH MIDGUT CARCINOID-TUMORS AND EVALUATION OF INTRAOPERATIVE SCINTILLATION DETECTION [J].

AHLMAN, H ;

WANGBERG, B ;

TISELL, LE ;

NILSSON, O ;

FJALLING, M ;

FORSSELLARONSSON, E .

BRITISH JOURNAL OF SURGERY, 1994, 81 (08) :1144-1149

[2]

Bader M, 1996, Recent Results Cancer Res, V142, P137

[3] INHIBITION OF CELL-PROLIFERATION BY THE SOMATOSTATIN ANALOG RC-160 IS MEDIATED BY SOMATOSTATIN RECEPTOR SUBTYPES SSTR2 AND SSTR5 THROUGH DIFFERENT MECHANISMS [J].

BUSCAIL, L ;

ESTEVE, JP ;

SAINTLAURENT, N ;

BERTRAND, V ;

REISINE, T ;

OCARROLL, AM ;

BELL, GI ;

SCHALLY, AV ;

VAYSSE, N ;

SUSINI, C .

PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA, 1995, 92 (05) :1580-1584

[4]

Buscail L, 1996, CANCER RES, V56, P1823

[5] STIMULATION OF TYROSINE PHOSPHATASE AND INHIBITION OF CELL-PROLIFERATION BY SOMATOSTATIN ANALOGS - MEDIATION BY HUMAN SOMATOSTATIN RECEPTOR SUBTYPES SSTR1 AND SSTR2 [J].

BUSCAIL, L ;

DELESQUE, N ;

ESTEVE, JP ;

SAINTLAURENT, N ;

PRATS, H ;

CLERC, P ;

ROBBERECHT, P ;

BELL, GI ;

LIEBOW, C ;

SCHALLY, AV ;

VAYSSE, N ;

SUSINI, C .

PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA, 1994, 91 (06) :2315-2319

[6]

Debono David J., 1996, Current Opinion in Oncology, V8, P112, DOI 10.1097/00001622-199603000-00007

[7]

Delesque N, 1997, CANCER RES, V57, P956

[8]

DELESQUE N, 1995, CIBA F SYMP, V190, P187

[9]

Janson ET, 1996, CANCER RES, V56, P2561

[10]

KRENNING EP, 1997, J NUCL MED, V38, pS47P

← 1 2 3 →